PHAR
Pharming Group
PHAR
PHAR
3 hedge funds and large institutions have $245K invested in Pharming Group in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, reducing their positions, and 0 closing their positions.
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$66K |
| 2 |
CPA
2
Cowen Prime Advisors
New York
|
$164K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$15K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CPA
1
Cowen Prime Advisors
New York
| $164K | 16,700 | +200 | +1% |
|
|
2
Morgan Stanley
New York
| $66K | 6,750 | +4,250 | +170% |
|
|
3
UBS Group
Zurich,
Switzerland
| $15K | 1,534 | +62 | +4% |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|